Lastest Insider Transactions Of Intellia Therapeutics, Inc. ( NTLA ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2024-01-08 | Sell | 2,275 | 28.87 | 65,682 | 2024-01-10 16:15:19 |
NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2024-01-03 | Sell | 19,223 | 29.46 | 566,310 | 2024-01-05 16:51:05 |
NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2024-01-03 | Sell | 5,843 | 29.46 | 172,135 | 2024-01-05 16:50:36 |
NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2024-01-03 | Sell | 5,532 | 29.46 | 162,973 | 2024-01-05 16:50:26 |
NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2024-01-03 | Sell | 5,365 | 29.46 | 158,053 | 2024-01-05 16:49:15 |
NTLA | Intellia Therapeutics, Inc. | Hicks Derek | EVP, Chief Business Officer | 2024-01-03 | Sell | 3,877 | 29.46 | 114,216 | 2024-01-05 16:46:39 |
NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | 2024-01-03 | Sell | 3,805 | 29.46 | 112,095 | 2024-01-05 16:45:39 |
NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2024-01-03 | Sell | 4,608 | 29.50 | 135,954 | 2024-01-05 16:44:43 |
NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2024-01-01 | Option Exercise | 3,500 | 0.00 | 0 | 2024-01-03 17:35:50 |
NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2024-01-01 | Option Exercise | 3,187 | 0.00 | 0 | 2024-01-03 17:34:10 |
NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2024-01-01 | Option Exercise | 7,848 | 0.00 | 0 | 2024-01-03 17:30:40 |
NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2024-01-01 | Option Exercise | 3,062 | 0.00 | 0 | 2024-01-03 17:28:42 |
NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Directior | 2023-10-31 | Sell | 265 | 23.90 | 6,334 | 2023-11-02 16:42:59 |
NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Directior | 2023-07-31 | Sell | 265 | 42.33 | 11,217 | 2023-08-02 17:19:39 |
NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Directior | 2023-07-06 | Sell | 1,867 | 39.30 | 73,373 | 2023-07-10 17:21:43 |
NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2023-07-03 | Sell | 360 | 40.51 | 14,584 | 2023-07-06 15:34:22 |
NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2023-06-20 | Sell | 5,000 | 45.00 | 225,000 | 2023-06-22 17:52:19 |
NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2023-06-20 | Option Exercise | 5,000 | 12.27 | 61,350 | 2023-06-22 17:52:19 |
NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | 2023-03-01 | Sell | 1,088 | 43.88 | 47,741 | 2023-03-03 17:10:35 |
NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2023-01-04 | Sell | 4,838 | 37.82 | 182,982 | 2023-01-06 17:39:56 |
NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2023-01-04 | Sell | 6,673 | 37.21 | 248,302 | 2023-01-06 17:32:49 |
NTLA | Intellia Therapeutics, Inc. | Hicks Derek | EVP, Chief Business Officer | 2023-01-04 | Sell | 1,812 | 37.21 | 67,425 | 2023-01-06 17:29:43 |
NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2023-01-04 | Sell | 2,574 | 37.21 | 95,779 | 2023-01-06 17:26:38 |
NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2023-01-04 | Sell | 2,427 | 37.21 | 90,309 | 2023-01-06 17:23:40 |
NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2022-07-01 | Sell | 2,028 | 37.65 | 76,357 | 2023-01-06 17:21:01 |
NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | 2023-01-04 | Sell | 1,138 | 37.21 | 42,345 | 2023-01-06 17:19:11 |
NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2023-01-01 | Option Exercise | 3,500 | 0.00 | 0 | 2023-01-04 20:38:29 |
NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2023-01-01 | Option Exercise | 7,848 | 0.00 | 0 | 2023-01-04 20:36:01 |
NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2023-01-01 | Option Exercise | 3,187 | 0.00 | 0 | 2023-01-04 20:33:03 |
NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2023-01-01 | Option Exercise | 3,062 | 0.00 | 0 | 2023-01-04 20:29:37 |